33rd European Congress of Pathology
Pathology: Compass for optimal patient therapy

29 - 31 August 2021 | virtual
European Society of Pathology (ESP)

Sunday, 8 September 2019

Monday, 9 September 2019

Tuesday, 10 September 2019

Wednesday, 11 September 2019

Monday, 9 September 2019


08:30 - 12:00

LC-02 | Pulmonary Pathology: Pleural tumours: biomarkers and new entities
  • LC-02-001-New insights in the diagnosis of mesothelioma
  • LC-02-003-Are there any new tissue biomarkers useful for diagnosis?
  • LC-02-004-Pathological grading of malignant pleural mesothelioma
LC-03 | Dermatopathology: Update in cutaneous soft tissue tumours
  • LC-03-001-Update in cutaneous fibrohistiocytic tumours
  • LC-03-003-Update in cutaneous tumours of uncertain histogenesis
  • LC-03-004-Update in cutaneous soft tissue tumours in children
  • LC-03-005-Questions on update on cutaneous neural tumours
MD-01 | Selected abstracts
  • MD-01-001-Plasma cfDNA testing of patienswith EGFR mutant non-small cell lung cancer
  • MD-01-002-Circulating Cell-free DNA in archived low quality volume serum samples: Rate of concordance with mutation in tumor
  • MD-01-003-Global delivery of external quality assessment for lung cancer liquid biopsy testing
OFP-04 | Breast Pathology
  • OFP-04-001-Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
  • OFP-04-003-The prognostic value of the tumour-stroma ratio validates in subgroups of breast cancer, especially in grade III tumours.
  • OFP-04-004-High Pregnane-X-Receptor (PXR) expression is correlated with poor prognosis in invasive breast carcinoma
  • OFP-04-005-The immune microenvironment in young patients with Triple Negative Breast Cancer
  • OFP-04-007-Correlation of the results of Ki67 in intristic subtypes of invasive breast carcinomas with the effect of systemic neoadjuvant treatment
  • OFP-04-008-Independent HER2-targeted therapy resistance predictors: intratumoural heterogeneity in breast carcinoma HER2 gene copy number and protein expression
  • OFP-04-009-Investigation of microRNA expression profiles related to morphological heterogeneity in triple-negative breast cancer
  • OFP-04-010-Ultra-fast and automated immunohistofluorescent multistaining using a microfluidic tissue processor
  • OFP-04-011-PD-L1 testing in triple negative breast cancer
  • OFP-04-012-Automatic quantification of HER2 amplification in invasive breast cancer using chromogenic in situ hybridization (CISH) and computational pathology
  • OFP-04-014-The impact of standardised structured reporting of pathology reports for breast cancer in the Netherlands
  • OFP-04-015-Correlation between primary tumour and axillary lymph node response to neoadjuvant chemotherapy in breast cancer patients
SC-04 | Joint Session Digestive Diseases Pathology & Rodger Haggitt Pathological Society: Syndromic polyps of the GI tract
  • SC-04-001-Gastric polyposis syndromes including neuroendocrine tumours
  • SC-04-002-Mesenchymal syndromic polyposes
  • SC-04-003-FAP, MAP and PPAP
  • SC-04-004-"Hamartomatous" polyposes
  • SC-04-005-Syndromic serrated lesions of the colon
SY-10 | Haematopathology: Technical advances in lymphoma diagnosis
  • SY-10-001-Mutational analysis vs cell of origin in diffuse large B-cell lymphoma, one or both?
  • SY-10-003-Traditional FISH or NGS approach?
  • SY-10-005-Mutational panel diagnosis for MDS/MPN, which panel to use?
SY-11 | Joint Session Paediatric and Perinatal Pathology / Uropathology: Unusual tumours of the kidney and urinary tract in children and adults
  • SY-11-001-RCC in children and young adults
  • SY-11-002-Urothelial tumours in children and young adults
  • SY-11-004-Rhabdomyosarcoma of genitourinary organs
  • SY-11-005-Other sarcomas of the kidney and GU tract
SY-12 | Neuropathology: Mixed neuronal-glial tumours
  • SY-12-001-Most frequent benign mixed neuronal-glial tumours
  • SY-12-004-New FISH tools in diagnosis of neuronal-glial tumours

12:15 - 13:00

KL-02 | Keynote Lecture by Jeroen van der Laak
  • KL-02-001-The rise of artificial intelligence and its impact on histopathology

14:45 - 16:45

MD-03 | Quality assurance and guidelines in molecular pathology
  • MD-03-001-ESP EQAs: impact on quality improvement
  • MD-03-003-IQN PATH: ring trial on liquid biopsy - introduction of trial concept
  • MD-03-004-IQN PATH: ring trial on liquid biopsy - results from the ESP-EQA
  • MD-03-005-UK NEQAS: NGS, variant nomenclature and reporting
  • MD-03-006-French quality assurance programme Gen&tiss
SC-05 | Joint Session Digestive Diseases Pathology & Hans Popper Hepatopathology Society: Hepatocellular carcinoma: from the basic to the complex
  • SC-05-001-HCC: pathogenesis, epidemiology, and diagnosis
  • SC-05-002-Classical histology vs. molecular pathology of HCC
  • SC-05-004-Immune checkpoint inhibitors in HCC: new data
  • SC-05-005-Cholangiolocarcinomas: where we are now
SC-06 | Dermatopathology: Update in adnexal tumours
  • SC-06-001-Update in sweat gland tumours
  • SC-06-002-Update in anogenital mammary-type gland tumours
  • SC-06-004-Update in sebaceous tumours
SS-04 | Haematopathology: The shifting sands of reactive vs. malignant lymphoproliferations
  • SS-04-001-Case 1
  • SS-04-002-Case 2
  • SS-04-003-Case 3
  • SS-04-004-Case 4
  • SS-04-006-Case 6
  • SS-04-008-Case 8
SS-05 | National Societies: Wolf in sheep's clothing or vice versa?
  • SS-05-002-Case 2
  • SS-05-003-Case 3
  • SS-05-004-Case 4
  • SS-05-005-Case 5
  • SS-05-006-Case 6
SY-13 | Pulmonary Pathology: Inside the void: cystic lung diseases
  • SY-13-001-Cystic lung lesions - the radiologist says: "My approach is..."
  • SY-13-002-Cystic lung lesions - the pathologist says: "My approach is..."
  • SY-13-003-Cystic lung lesions in pediatric population
  • SY-13-004-Rare lung cystic lesions (light chain disease, amiloidosis, Birt-Hogg-Dubé and metastasis)
SY-14 | Joint Session Neuropathology / Electron Microscopy: Storage diseases and neuropathology: diagnosis and new treatment strategies
  • SY-14-001-Storage disease and myopathies: diagnosis and therapeutic approach
  • SY-14-002-Myofibrillar myopathies and other disorders with protein accumulation?
SY-15 | IT in Pathology: Guidelines and gold standards in digital pathology
  • SY-15-001-Guidelines of the German Professional Association
  • SY-15-003-Present stage of DICOM in virtual pathology

17:15 - 19:15

MD-04 | NGS - beyond mutation testing
  • MD-04-001-AMP guidelines for variant reporting
  • MD-04-002-CNV detection from NGS data
  • MD-04-003-Fusion gene detection using RNAseq
  • MD-04-004-Moving beyond DNA sequence: genome-wide profiling of plasma DNA
OFP-05 | Digestive Diseases Pathology - Liver / Pancreas
  • OFP-05-002-A gene expression signature of microvascular invasion in hepatocellular carcinoma in formalin fixed-paraffin embedded biopisies
  • OFP-05-003-Imaging mass spectrometry to differentiate between pancreatic adenocarcinoma and cholangiocarcinoma
  • OFP-05-004-Transarterial chemoembolization enhances programmed death-1 and programmed death ligand-1 expression in hepatocellular carcinoma
  • OFP-05-005-Vessels Encapsulating Tumor Clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma (HCC)
  • OFP-05-007-SMAD4 deficient pancreatic adenocarcinoma are poor prognosis tumours associated with histopathological aggressive features
  • OFP-05-009-Expression of GRP78 protein is increased in pancreatic ductal adenocarcinoma, pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm
  • OFP-05-010-Prognostic value of desmoplastic stroma in intra-hepatic cholangiocarcinoma
  • OFP-05-011-MSI in intestinal immunophenotype in ampullary and pancreatic cancer
OFP-06 | Joint Session: Endocrine Pathology / Head and Neck Pathology
  • OFP-06-001-IgG4 thyroiditis: similarity to and differences from IgG4-related disease
  • OFP-06-002-Is preoperative RAS or BRAF K601E mutations cytologic detection useful for clinical management of indeterminate thyroid nodules, according to the new WHO classification?
  • OFP-06-005-Immunohistochemical evaluation of CXCR4 chemokine receptor expression in metastatic and nonmetastatic well-differentiated pancreatic neuroendocrine tumours
  • OFP-06-007-Genetic heterogeneity in adjacent normal mucosa of oral squamous cell carcinoma is a marker of poor prognosis
  • OFP-06-008-Prognostic impact of DNA methylation analysis in adjacent area of surgically resected oral squamous cell carcinoma during follow up
  • OFP-06-010-Clinicopathological characterisation and outcomes analysis of a single-institutional cohort of early-stage oral tongue squamous cell carcinoma treated by surgery alone
  • OFP-06-011-Evaluation of programmed death ligand-1 expression and efficacy outcomes in patients with squamous cell carcinoma of the head and neck from KEYNOTE-040 using two scoring techniques
  • OFP-06-012-Surgical follow-up of ThyroSeq® positive thyroid nodules: the Memorial Sloan Kettering Cancer Center experience
OFP-07 | Dermatopathology
  • OFP-07-001-Assessment of circulating tumour cells and circulating cell-free DNA in patients with metastatic melanoma
  • OFP-07-002-Intravascular nevus cell protrusion and aggregates in otherwise common melanocytic nevi
  • OFP-07-004-E-cadherin and N-cadherin expression pattern in common melanocytic nevi
  • OFP-07-005-A PD-L1 IHC 28-8 PharmDX ring trial on metastatic melanoma: practical aspects
  • OFP-07-006-Imbalance between types I and VI collagen promotes skin fragility in human and experimental diabetes
  • OFP-07-007-Melanomas with spindle cell differentiation: a review of clinical, pathological and molecular characteristics
  • OFP-07-008-YAP1 expression in Merkel Cell Carcinoma
  • OFP-07-009-A 5-year retrospective analysis of all cutaneous metastases from a single dermatopathology unit
  • OFP-07-011-The role of CD123 positive plasmacytoid dendritic cells in cutaneous lupus erythematosus
OFP-08 | Joint Session: Neuropathology / Ophthalmic Pathology
  • OFP-08-001-Deregulated expression of imprinted DLK1-DIO3 region in glioblastoma stem-like cells: tumour suppressor role of lncRNA MEG3
  • OFP-08-002-Ki-67 and MCM6 labelling index are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q codeleted: a multicenter study from the French POLA Network
  • OFP-08-003-Utra-mutated IDH wild-type glioblastomas in patients younger than 50 years have peculiar histopathology and better prognosis
  • OFP-08-004-Clinical variability in Gerstmann-Sträussler-Scheinker syndrome with the P102L mutation
  • OFP-08-006-The quantification of the methylation status of methyl-guanil-methyl-transferase gene (MGMT) by prosequencing from macrodissected paraffin embedded tumours is a relevant prognostic parameter in glioblastoma
  • OFP-08-007-The place and prognostic value of TERT promoter mutation in molecular classification in grade II-III glial tumours and primary glioblastomas
  • OFP-08-008-Clinicopathological characterisation of gliomas with H3-K27M mutation: a case series
  • OFP-08-010-Clinical significance of Ephrin receptor (Eph)-A1, -A5 and -A7 expression in uveal melanoma
  • OFP-08-011-Histone Deacetylase-2 expression predicts survival in uveal melanoma patients
SC-07 | Haematopathology: Advances in extranodal lymphomas
  • SC-07-001-Lymphomas in the skin
  • SC-07-002-Lymphomas of the gastrointestinal tract
  • SC-07-003-Challenging cases in extranodal lymphomas
  • SC-07-004-The particular biology of lymphomas in immune privileged sites
SS-06 | Joint Session Pulmonary Pathology / Thymic and Mediastinal Pathology: Rare tumours of mediastinum
  • SS-06-002-Case 2
  • SS-06-003-Case 3
  • SS-06-004-Case 4
SS-07 | Joint Session Nephropathology / Electron Microscopy: Electron microscopy differential diagnosis of glomerular deposits
  • SS-07-001-Case 1
  • SS-07-002-Case 2
  • SS-07-003-Case 3
  • SS-07-004-Case 4
  • SS-07-006-Case 6
  • SS-07-007-Clinical discussion of cases
SY-16 | Joint Session Autopsy Pathology / IT in Pathology: The autopsy: a perspective of education and training in pathology
  • SY-16-002-From knowledge and understanding to education, research and communication in digital pathology - state of the art and perspectives
  • SY-16-003-Teaching in the autopsy room; experiences from Texas
  • SY-16-004-Teaching in the autopsy room; experiences from Poland
  • SY-16-005-Teaching in the autopsy room, experiences from Denmark and other low-rate countries